Amelanotic melanoma is an extremely rare subtype of cutaneous melanoma. The tumor characteristics are still not well understood, especially for those located in the head and neck.Tumor characteristics of patients …
Prospective study on hand dermatitis in nurses and doctors during COVID-19 pandemic and its improvement by use of adopted recommendations of the European Academy of Dermatology and Venereology Task Force on Contact Dermatitis.
Frequency of hand disinfection and adverse skin reactions among health care workers dramatically increased since the COVID-19 outbreak and consensus recommendations on hand hygiene were presented. The aim of the …
Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic – an original epidemiological, clinical, dermoscopic, and laboratory-based study.
An association between wearing protective gear and eosinophilic folliculitis has not been reported. We aimed to investigate such during the COVID-19 pandemic.In three outpatient clinics, we hand-reviewed records of all …
EFFECTIVENESS OF DUTASTERIDE IN A LARGE SERIES OF PATIENTS WITH FRONTAL FIBROSING ALOPECIA IN REAL CLINICAL PRACTICE.
Dutasteride has been proposed as an effective therapy for frontal fibrosing alopecia (FFA).To describe the therapeutic response to dutasteride and the most effective dosage in FFA compared to other therapeutic …
Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: a propensity score-matched cohort study.
Dupilumab is an effective treatment for moderate to severe atopic dermatitis (AD) with limited safety data in clinical practice.To assess the 6-month risk of conjunctivitis and serious infections in patients …
T2DM Links to Risk for Dementia Differ by Type, Glycemic Control
Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol
CDC: U.S. COVID-19 Deaths Could Reach 233,000 by End of October
And, dual coronavirus-flu vaccine to start human trials
Remdesivir Cuts Time to COVID-19 Recovery
However, no significant difference in mortality found between remdesivir and placebo groups
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 5 to 9, 2020. This …
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries